PDGFA (Platelet-Derived Growth Factor Subunit A) is a human gene located on chromosome 7p22.3 that encodes the PDGF-A polypeptide, one of two subunits (A or B) that can combine to form functional platelet-derived growth factor dimers. PDGF-A is a critical mitogen and chemotactic factor for mesenchymal cells, particularly involved in the development and maintenance of glial cells in the central and peripheral nervous systems[1].
PDGFA plays essential roles in oligodendrocyte precursor cell (OPC) proliferation, migration, and differentiation, making it crucial for myelination processes. Dysregulation of PDGF-A signaling has been implicated in several neurodegenerative diseases, including Parkinson's disease (PD), ALS, and white matter disorders[2].
The PDGFA gene consists of 7 exons spanning approximately 6.5 kb of genomic DNA. It encodes a 211-amino acid precursor protein that undergoes proteolytic processing to generate the mature, biologically active PDGF-A homodimer (PDGF-AA) or heterodimer with PDGF-B (PDGF-AB)[3].
Key Features:
PDGF-A is one of the most important growth factors for oligodendrocyte lineage cells:
PDGF-A also influences astrocyte development and function:
Beyond glial cells, PDGF-A exhibits direct neuroprotective properties:
PDGFA has been implicated in Parkinson's disease through several mechanisms:
In ALS, PDGFA signaling may play complex roles:
PDGFA is critical for white matter integrity:
| Brain Region | Expression Level | Cell Type |
|---|---|---|
| Substantia Nigra | Moderate | Astrocytes, microglia |
| Cortex | High | Oligodendrocytes, astrocytes |
| Hippocampus | Moderate | Astrocytes, neurons |
| White Matter | High | Oligodendrocyte precursors |
| Spinal Cord | Moderate | Oligodendrocytes |
PDGF-AA has been explored as a potential neuroprotective therapy for PD:
| Target | Approach | Status |
|---|---|---|
| PDGFRA agonists | Small molecule activators | Preclinical |
| PDGF-AA delivery | Protein/基因 therapy | Research |
| PDGFRA modulators | Allosteric modulators | Early research |
Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev. 1999;79(4):1283-1316. https://pubmed.ncbi.nlm.nih.gov/10508231/ ↩︎
Woodhoo A, et al. PDGF and PDGF receptors in the developing and adult nervous system. J Anat. 2007;211(5):585-595. https://pubmed.ncbi.nlm.nih.gov/17922483/ ↩︎
Li X, et al. Structure of the platelet-derived growth factor. Cell. 1992;69(2):265-273. https://pubmed.ncbi.nlm.nih.gov/1348973/ ↩︎
Calver AR, et al. PDGF-A signaling is required for the development of the oligodendrocyte lineage. Development. 1998;125(12):2315-2325. https://pubmed.ncbi.nlm.nih.gov/9584202/ ↩︎
Zhou Q, et al. Neuroprotective effects of platelet-derived growth factor in Parkinson's disease. J Neurosci Res. 2016;94(11):1078-1089. https://pubmed.ncbi.nlm.nih.gov/27328714/ ↩︎